ReviewCancers2026

Efficacy and Safety of Daraxonrasib (RMC-6236) in Previously Treated Metastatic RAS-Mutated Pancreatic Ductal Adenocarcinoma: A Systematic Review.

Natalia Gierulska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.